Search - tctmd.com

Displaying 21 - 40 of 115

Sort: Relevancy | Date

News Conference News ACC 2024

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Michael O'Riordan

April 07, 2024

Presentation THT 2024

Inotropes and Mortality in Patients With Cardiogenic Shock Due to Myocardial Infarction: Insights from the SWEDEHEART Registry

Presenter: Elmir Omerovic

March 05, 2024

News Daily News

No Benefit to P2Y12 Inhibitor Pretreatment in STEMI, Bern-PCI Data Confirm

Yael L. Maxwell

January 10, 2024

News Conference News TCT 2023

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

Caitlin E. Cox

October 26, 2023

Presentation TCT 2023

Long-term Clinical Outcomes After iFR vs. FFR Guided Coronary Revascularization – Insights From the SWEDEHEART National Registry

Presenter: Matthias Götberg

October 25, 2023

News Conference News EACTS 2023

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

Michael O'Riordan

October 05, 2023

News Conference News EuroPCR 2023

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Michael O'Riordan

May 18, 2023

News Daily News

Swedish Study Adds to Evidence That Beta-blockers May Not Be Needed Long After MI

Todd Neale

May 05, 2023

News Daily News

ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA

Todd Neale

December 16, 2022

News Conference News AHA 2022

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

Shelley Wood

November 06, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2022

Shelley Wood

October 31, 2022

News Conference News EACTS 2022

FFR/iFR No Help in CABG Surgery in SWEDEHEART Registry

Michael O'Riordan

October 07, 2022

Podcast TCTMD Talking Points

iFR-SWEDEHEART at 5 Years

August 03, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

News Daily News

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

Shelley Wood

December 22, 2021

News Daily News

SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS

L.A. McKeown

November 30, 2021

News Conference News TCT 2021

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

Caitlin E. Cox

November 04, 2021

Presentation TCT 2021

iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI

Presenter: Matthias Götberg

November 04, 2021

News Daily News

SWEDEHEART Data Reassure on 10-Year Survival for TAVI Patients With Pacemakers

Caitlin E. Cox

October 05, 2021

News Daily News

Studies Explore Post-MI Use of Beta-blockers, Mineralocorticoid Receptor Antagonists

Todd Neale

July 09, 2021

Advertisement

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Inotropes and Mortality in Patients With Cardiogenic Shock Due to Myocardial Infarction: Insights from the SWEDEHEART Registry

No Benefit to P2Y12 Inhibitor Pretreatment in STEMI, Bern-PCI Data Confirm

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

Long-term Clinical Outcomes After iFR vs. FFR Guided Coronary Revascularization – Insights From the SWEDEHEART National Registry

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Swedish Study Adds to Evidence That Beta-blockers May Not Be Needed Long After MI

ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

TCTMD’s Top 10 Most Popular Stories for October 2022

FFR/iFR No Help in CABG Surgery in SWEDEHEART Registry

iFR-SWEDEHEART at 5 Years

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI

SWEDEHEART Data Reassure on 10-Year Survival for TAVI Patients With Pacemakers

Studies Explore Post-MI Use of Beta-blockers, Mineralocorticoid Receptor Antagonists

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content